H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs UBS Securities LLC

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513
Entity B
UBS Securities LLC
TNRank #FEIN 13-3873456

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPUBS Securities LLC
Total filings80,8131,332
Certified %98.23%79.58%
Denied %1.09%1.35%
Withdrawn %0.61%9.53%
Cert-withdrawn %0.07%9.53%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2026
Worksite statePATN

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Outcomes — UBS Securities LLC

DOL case-status mix.

Outcome breakdown: Certified 79.6%, Cert-withdrawn 9.5%, Withdrawn 9.5%, Denied 1.4%
Outcome breakdown
OutcomeShare
Certified79.6%
Cert-withdrawn9.5%
Withdrawn9.5%
Denied1.4%
Certified79.6%
Cert-withdrawn9.5%
Withdrawn9.5%
Denied1.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612
UBS Securities LLC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY2010130
FY201185
FY2012103
FY201390
FY2014114
FY2015117
FY2016122
FY201797
FY201877
FY201981
FY202013
FY202121
FY20229
FY202329
FY202448
FY2025117
FY202679

Top 5 occupations — Deloitte Consulting LLP

Top 5 occupations — UBS Securities LLC

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.